chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 46.0
Sex: M
Vaccine: COVID19
Symptoms: Chest X-ray, Chills, Computerised tomogram, Cough, Dyspnoea
Clinical narrative: Cough; Trouble drawing a full breath(described as not constant, but there throughout the day; easily more winded after any sort of excercise); Poor sleep; Chills; Fatigue; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of DYSPNOEA (Trouble drawing a full breath(described as not constant, but there throughout the day; easily more winded after any sort of excercise)), COUGH (Cough), POOR QUALITY SLEEP (Poor sleep), CHILLS (Chills) and FATIGUE (Fatigue) in a 46-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032M26A and 032M20A) for COVID-19 vaccination.     No medical history was provided.  Concomitant products included PREDNISOLONE ACETATE, TIMOLOL MALEATE (BETIMOL [TIMOLOL MALEATE]) and OMEPRAZOLE for an unknown indication.   On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 14-Apr-2021, the patient experienced POOR QUALITY SLEEP (Poor sleep), CHILLS (Chills) and FATIGUE (Fatigue). On 19-Apr-2021, the patient experienced DYSPNOEA (Trouble drawing a full breath(described as not constant, but there throughout the day; easily more winded after any sort of excercise)). On 26-Apr-2021, the patient experienced COUGH (Cough). On 15-Apr-2021, POOR QUALITY SLEEP (Poor sleep), CHILLS (Chills) and FATIGUE (Fatigue) had resolved. At the time of the report, DYSPNOEA (Trouble drawing a full breath(described as not constant, but there throughout the day; easily more winded after any sort of excercise)) and COUGH (Cough) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 22-Apr-2021, SARS-CoV-2 test: (Negative) patient got a COVID test, and tested negative.. On 28-Apr-2021, Computerised tomogram: (abnormal) patient went for an outpatient chest CT scan, which revealed that his lungs were mildly hyperinflated.. On an unknown date, Chest X-ray: (normal) chest X-ray (which showed no fluids or masses).. On an unknown date, Oxygen saturation: (abnormal) physician took a pulse oximetry test (which showed that the patient's oxygen saturation went down after any sort of mild exertion).     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment provided was Advil a couple of times.  Description: 28Apr2021, the patient went for an outpatient chest CT scan, which revealed that his lungs were mildly hyperinflated.
Age: 46.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Oxygen saturation, Poor quality sleep, SARS-CoV-2 test
Clinical narrative: Cough; Trouble drawing a full breath(described as not constant, but there throughout the day; easily more winded after any sort of excercise); Poor sleep; Chills; Fatigue; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of DYSPNOEA (Trouble drawing a full breath(described as not constant, but there throughout the day; easily more winded after any sort of excercise)), COUGH (Cough), POOR QUALITY SLEEP (Poor sleep), CHILLS (Chills) and FATIGUE (Fatigue) in a 46-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032M26A and 032M20A) for COVID-19 vaccination.     No medical history was provided.  Concomitant products included PREDNISOLONE ACETATE, TIMOLOL MALEATE (BETIMOL [TIMOLOL MALEATE]) and OMEPRAZOLE for an unknown indication.   On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 14-Apr-2021, the patient experienced POOR QUALITY SLEEP (Poor sleep), CHILLS (Chills) and FATIGUE (Fatigue). On 19-Apr-2021, the patient experienced DYSPNOEA (Trouble drawing a full breath(described as not constant, but there throughout the day; easily more winded after any sort of excercise)). On 26-Apr-2021, the patient experienced COUGH (Cough). On 15-Apr-2021, POOR QUALITY SLEEP (Poor sleep), CHILLS (Chills) and FATIGUE (Fatigue) had resolved. At the time of the report, DYSPNOEA (Trouble drawing a full breath(described as not constant, but there throughout the day; easily more winded after any sort of excercise)) and COUGH (Cough) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 22-Apr-2021, SARS-CoV-2 test: (Negative) patient got a COVID test, and tested negative.. On 28-Apr-2021, Computerised tomogram: (abnormal) patient went for an outpatient chest CT scan, which revealed that his lungs were mildly hyperinflated.. On an unknown date, Chest X-ray: (normal) chest X-ray (which showed no fluids or masses).. On an unknown date, Oxygen saturation: (abnormal) physician took a pulse oximetry test (which showed that the patient's oxygen saturation went down after any sort of mild exertion).     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment provided was Advil a couple of times.  Description: 28Apr2021, the patient went for an outpatient chest CT scan, which revealed that his lungs were mildly hyperinflated.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Body temperature, Eye pain, Feeling abnormal, Headache
Clinical narrative: headache; Aches and pains/ body hurts; wrist hurts; temperature 99.8 F; my eyes hurt, feel better when closed; sweating; just don't feel good; This spontaneous case was reported by a consumer and describes the occurrence of EYE PAIN (my eyes hurt, feel better when closed), HYPERHIDROSIS (sweating), FEELING ABNORMAL (just don't feel good), HEADACHE (headache) and MYALGIA (Aches and pains/ body hurts) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025B21A and 017B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included MESALAMINE, VITAMIN D2, CALCIUM, COLECALCIFEROL (CALCIUM + VITAMIN D3) and ALGAECAL PLUS for an unknown indication.   On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 29-Apr-2021, the patient experienced EYE PAIN (my eyes hurt, feel better when closed), HYPERHIDROSIS (sweating), FEELING ABNORMAL (just don't feel good), MYALGIA (Aches and pains/ body hurts), ARTHRALGIA ( wrist hurts) and PYREXIA (temperature 99.8 F). On 29-Apr-2021 at 4:00 AM, the patient experienced HEADACHE (headache). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 500 mg. At the time of the report, EYE PAIN (my eyes hurt, feel better when closed), HYPERHIDROSIS (sweating), FEELING ABNORMAL (just don't feel good), HEADACHE (headache), MYALGIA (Aches and pains/ body hurts), ARTHRALGIA ( wrist hurts) and PYREXIA (temperature 99.8 F) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 29-Apr-2021, Body temperature: 99.8 (High) Body temperature was 99.8 F.         Concomitant medication taken by the patient included  Multicomplete. The patient took two tablets of Tylenol 500 mg each by mouth as a corrective treatment at noon on 29-Apr-2021 and woke up sweating at 2-2:30 pm. The action taken for mRNA-1273 was not applicable.   This case was linked to MOD-2021-098136 (Patient Link).
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Hyperhidrosis, Myalgia, Pyrexia
Clinical narrative: headache; Aches and pains/ body hurts; wrist hurts; temperature 99.8 F; my eyes hurt, feel better when closed; sweating; just don't feel good; This spontaneous case was reported by a consumer and describes the occurrence of EYE PAIN (my eyes hurt, feel better when closed), HYPERHIDROSIS (sweating), FEELING ABNORMAL (just don't feel good), HEADACHE (headache) and MYALGIA (Aches and pains/ body hurts) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025B21A and 017B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included MESALAMINE, VITAMIN D2, CALCIUM, COLECALCIFEROL (CALCIUM + VITAMIN D3) and ALGAECAL PLUS for an unknown indication.   On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 29-Apr-2021, the patient experienced EYE PAIN (my eyes hurt, feel better when closed), HYPERHIDROSIS (sweating), FEELING ABNORMAL (just don't feel good), MYALGIA (Aches and pains/ body hurts), ARTHRALGIA ( wrist hurts) and PYREXIA (temperature 99.8 F). On 29-Apr-2021 at 4:00 AM, the patient experienced HEADACHE (headache). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 500 mg. At the time of the report, EYE PAIN (my eyes hurt, feel better when closed), HYPERHIDROSIS (sweating), FEELING ABNORMAL (just don't feel good), HEADACHE (headache), MYALGIA (Aches and pains/ body hurts), ARTHRALGIA ( wrist hurts) and PYREXIA (temperature 99.8 F) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 29-Apr-2021, Body temperature: 99.8 (High) Body temperature was 99.8 F.         Concomitant medication taken by the patient included  Multicomplete. The patient took two tablets of Tylenol 500 mg each by mouth as a corrective treatment at noon on 29-Apr-2021 and woke up sweating at 2-2:30 pm. The action taken for mRNA-1273 was not applicable.   This case was linked to MOD-2021-098136 (Patient Link).
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Gait disturbance, Incorrect route of product administration, Pain, Pain in extremity
Clinical narrative: Legs hurt so bad after 1st dose/pain in legs; Couldn't walk after 1st dose; Pain worse in right leg after 1st dose; Given a medication intravenously; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Legs hurt so bad after 1st dose/pain in legs), GAIT DISTURBANCE (Couldn't walk after 1st dose), PAIN (Pain worse in right leg after 1st dose) and INCORRECT ROUTE OF PRODUCT ADMINISTRATION (Given a medication intravenously) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025b21a) for COVID-19 vaccination.     The patient's past medical history included COVID-19 (Patient had COVID-19 in January, as reported.) in January 2021 and Device implant NOS (Patient has bolts and screws in her left arm). Concurrent medical conditions included Neuropathy. Concomitant products included CLOPIDOGREL BISULFATE (PLAVIX) and ASPIRIN [ACETYLSALICYLIC ACID] for Clot blood, GABAPENTIN for an unknown indication.    On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intravenous) 1 dosage form. On 06-Apr-2021, the patient experienced PAIN IN EXTREMITY (Legs hurt so bad after 1st dose/pain in legs), GAIT DISTURBANCE (Couldn't walk after 1st dose), PAIN (Pain worse in right leg after 1st dose) and INCORRECT ROUTE OF PRODUCT ADMINISTRATION (Given a medication intravenously). The patient was treated with IBUPROFEN for Pain, at an unspecified dose and frequency. On 06-Apr-2021, INCORRECT ROUTE OF PRODUCT ADMINISTRATION (Given a medication intravenously) had resolved. At the time of the report, PAIN IN EXTREMITY (Legs hurt so bad after 1st dose/pain in legs), GAIT DISTURBANCE (Couldn't walk after 1st dose) and PAIN (Pain worse in right leg after 1st dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intravenous) was unknown.       Other Concomitant product includes Parkinson's Medication
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site bruising, Injection site erythema, Injection site pain, Pharyngeal swelling, Vaccination site movement impairment
Clinical narrative: Site of injection is bruised; She can barely lift her arm; Arm  became really sore a few hours post vaccination; Her arm also became red spanning about 3 inches; Patient reports feeling "like her throat was swelling; Her arm also became red and hot; This spontaneous case was reported by a consumer and describes the occurrence of PHARYNGEAL SWELLING (Patient reports feeling "like her throat was swelling), VACCINATION SITE WARMTH (Her arm also became red and hot), INJECTION SITE BRUISING (Site of injection is bruised), VACCINATION SITE MOVEMENT IMPAIRMENT (She can barely lift her arm) and INJECTION SITE PAIN (Arm  became really sore a few hours post vaccination) in a 24-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 021B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Asthma and Fruit allergy (watermelon, cantaloupe, honeydew and apples (patient reports she develops hives and her lips, tongue, and throat swell after consuming the aforementioned fruits).). Concomitant products included ALBUTEROL [SALBUTAMOL] and ETONOGESTREL (NEXPLANON) for an unknown indication.    On 28-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Apr-2021, the patient experienced PHARYNGEAL SWELLING (Patient reports feeling "like her throat was swelling), VACCINATION SITE WARMTH (Her arm also became red and hot), INJECTION SITE PAIN (Arm  became really sore a few hours post vaccination) and INJECTION SITE ERYTHEMA (Her arm also became red spanning about 3 inches). On 29-Apr-2021, the patient experienced INJECTION SITE BRUISING (Site of injection is bruised) and VACCINATION SITE MOVEMENT IMPAIRMENT (She can barely lift her arm). On 28-Apr-2021, PHARYNGEAL SWELLING (Patient reports feeling "like her throat was swelling) had resolved. At the time of the report, VACCINATION SITE WARMTH (Her arm also became red and hot), INJECTION SITE BRUISING (Site of injection is bruised), VACCINATION SITE MOVEMENT IMPAIRMENT (She can barely lift her arm), INJECTION SITE PAIN (Arm  became really sore a few hours post vaccination) and INJECTION SITE ERYTHEMA (Her arm also became red spanning about 3 inches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Treatment information was reported.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site warmth
Clinical narrative: Site of injection is bruised; She can barely lift her arm; Arm  became really sore a few hours post vaccination; Her arm also became red spanning about 3 inches; Patient reports feeling "like her throat was swelling; Her arm also became red and hot; This spontaneous case was reported by a consumer and describes the occurrence of PHARYNGEAL SWELLING (Patient reports feeling "like her throat was swelling), VACCINATION SITE WARMTH (Her arm also became red and hot), INJECTION SITE BRUISING (Site of injection is bruised), VACCINATION SITE MOVEMENT IMPAIRMENT (She can barely lift her arm) and INJECTION SITE PAIN (Arm  became really sore a few hours post vaccination) in a 24-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 021B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Asthma and Fruit allergy (watermelon, cantaloupe, honeydew and apples (patient reports she develops hives and her lips, tongue, and throat swell after consuming the aforementioned fruits).). Concomitant products included ALBUTEROL [SALBUTAMOL] and ETONOGESTREL (NEXPLANON) for an unknown indication.    On 28-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Apr-2021, the patient experienced PHARYNGEAL SWELLING (Patient reports feeling "like her throat was swelling), VACCINATION SITE WARMTH (Her arm also became red and hot), INJECTION SITE PAIN (Arm  became really sore a few hours post vaccination) and INJECTION SITE ERYTHEMA (Her arm also became red spanning about 3 inches). On 29-Apr-2021, the patient experienced INJECTION SITE BRUISING (Site of injection is bruised) and VACCINATION SITE MOVEMENT IMPAIRMENT (She can barely lift her arm). On 28-Apr-2021, PHARYNGEAL SWELLING (Patient reports feeling "like her throat was swelling) had resolved. At the time of the report, VACCINATION SITE WARMTH (Her arm also became red and hot), INJECTION SITE BRUISING (Site of injection is bruised), VACCINATION SITE MOVEMENT IMPAIRMENT (She can barely lift her arm), INJECTION SITE PAIN (Arm  became really sore a few hours post vaccination) and INJECTION SITE ERYTHEMA (Her arm also became red spanning about 3 inches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Treatment information was reported.
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia oral
Clinical narrative: tongue numbness; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA ORAL (tongue numbness) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HYPOAESTHESIA ORAL (tongue numbness). At the time of the report, HYPOAESTHESIA ORAL (tongue numbness) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant Medication was provided. No treatment  was provided.
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, Headache, Vaccination site pain
Clinical narrative: Slight headache; Soreness at the injection site; Out of date vaccine given; This spontaneous case was reported by a pharmacist and describes the occurrence of HEADACHE (Slight headache), VACCINATION SITE PAIN (Soreness at the injection site) and EXPIRED PRODUCT ADMINISTERED (Out of date vaccine given) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042b21a) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Apr-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Out of date vaccine given). On an unknown date, the patient experienced HEADACHE (Slight headache) and VACCINATION SITE PAIN (Soreness at the injection site). On 29-Apr-2021, EXPIRED PRODUCT ADMINISTERED (Out of date vaccine given) had resolved. At the time of the report, HEADACHE (Slight headache) and VACCINATION SITE PAIN (Soreness at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication were provided  Treatment medication was not provided   Most recent FOLLOW-UP information incorporated above includes: On 28-Jun-2021: Follow up received on 28-Jun-2021, events were added, slight headache and soreness at the injection site.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Dry mouth, Fatigue, Feeling cold, Headache
Clinical narrative: her varicose veins started hurting; feels cold, her hands feel frozen; Lips are split; Mouth feels dry; very thirsty and even if she drinks water, it won't go away; hasn't been able to go to work for two days; diarrhea  mild; vomiting; headache that only today got tolerable; body ache; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of VARICOSE VEIN (her varicose veins started hurting), FEELING COLD (feels cold, her hands feel frozen), LIP INJURY (Lips are split), DRY MOUTH (Mouth feels dry) and THIRST (very thirsty and even if she drinks water, it won't go away) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 02032A and 040A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Palpitations (before the vaccines, she had an episode of palpitations), Swollen ankles (before the vaccines, left ankle got swollen) and Vein pain (before the vaccines , the veins hurted).   On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 27-Apr-2021, the patient experienced FEELING COLD (feels cold, her hands feel frozen), LIP INJURY (Lips are split), DRY MOUTH (Mouth feels dry), THIRST (very thirsty and even if she drinks water, it won't go away), IMPAIRED WORK ABILITY (hasn't been able to go to work for two days), DIARRHOEA (diarrhea  mild), VOMITING (vomiting), HEADACHE (headache that only today got tolerable), MYALGIA (body ache) and FATIGUE (fatigue). On an unknown date, the patient experienced VARICOSE VEIN (her varicose veins started hurting). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, VARICOSE VEIN (her varicose veins started hurting) had not resolved and FEELING COLD (feels cold, her hands feel frozen), LIP INJURY (Lips are split), DRY MOUTH (Mouth feels dry), THIRST (very thirsty and even if she drinks water, it won't go away), IMPAIRED WORK ABILITY (hasn't been able to go to work for two days), DIARRHOEA (diarrhea  mild), VOMITING (vomiting), HEADACHE (headache that only today got tolerable), MYALGIA (body ache) and FATIGUE (fatigue) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Medical observation: inconclusive (Inconclusive) Patient went to the hospital where the nurse practitioner did a vein exam  and told her she seemed fine..         No relevant concomitant medications were provided. The action taken for mRNA-1273 was not applicable.   This case was linked to MOD-2021-098160 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 31-May-2021: Follow-up information was received and  reporter information, laboratory information , a new event varicose vein, outcome of events were updated.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Varicose vein, Vomiting
Clinical narrative: her varicose veins started hurting; feels cold, her hands feel frozen; Lips are split; Mouth feels dry; very thirsty and even if she drinks water, it won't go away; hasn't been able to go to work for two days; diarrhea  mild; vomiting; headache that only today got tolerable; body ache; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of VARICOSE VEIN (her varicose veins started hurting), FEELING COLD (feels cold, her hands feel frozen), LIP INJURY (Lips are split), DRY MOUTH (Mouth feels dry) and THIRST (very thirsty and even if she drinks water, it won't go away) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 02032A and 040A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Palpitations (before the vaccines, she had an episode of palpitations), Swollen ankles (before the vaccines, left ankle got swollen) and Vein pain (before the vaccines , the veins hurted).   On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 27-Apr-2021, the patient experienced FEELING COLD (feels cold, her hands feel frozen), LIP INJURY (Lips are split), DRY MOUTH (Mouth feels dry), THIRST (very thirsty and even if she drinks water, it won't go away), IMPAIRED WORK ABILITY (hasn't been able to go to work for two days), DIARRHOEA (diarrhea  mild), VOMITING (vomiting), HEADACHE (headache that only today got tolerable), MYALGIA (body ache) and FATIGUE (fatigue). On an unknown date, the patient experienced VARICOSE VEIN (her varicose veins started hurting). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, VARICOSE VEIN (her varicose veins started hurting) had not resolved and FEELING COLD (feels cold, her hands feel frozen), LIP INJURY (Lips are split), DRY MOUTH (Mouth feels dry), THIRST (very thirsty and even if she drinks water, it won't go away), IMPAIRED WORK ABILITY (hasn't been able to go to work for two days), DIARRHOEA (diarrhea  mild), VOMITING (vomiting), HEADACHE (headache that only today got tolerable), MYALGIA (body ache) and FATIGUE (fatigue) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Medical observation: inconclusive (Inconclusive) Patient went to the hospital where the nurse practitioner did a vein exam  and told her she seemed fine..         No relevant concomitant medications were provided. The action taken for mRNA-1273 was not applicable.   This case was linked to MOD-2021-098160 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 31-May-2021: Follow-up information was received and  reporter information, laboratory information , a new event varicose vein, outcome of events were updated.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Hyperhidrosis, Pyrexia
Clinical narrative: chills; sweating; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills) and HYPERHIDROSIS (sweating) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002021A and 028PL1A) for COVID-19 vaccination.     No Medical History information was reported.   On 21-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 29-Apr-2021, the patient experienced CHILLS (chills) and HYPERHIDROSIS (sweating). At the time of the report, CHILLS (chills) and HYPERHIDROSIS (sweating) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 29-Apr-2021, Pyrexia: 101.6 f (Inconclusive) Fever of 101.6 F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Cystitis interstitial, Parosmia, Taste disorder
Clinical narrative: interstitial cystitis was improved; smell hot electric wire (on and off); tasted weird things in mouth; This spontaneous case was reported by a consumer and describes the occurrence of CYSTITIS INTERSTITIAL (interstitial cystitis was improved), PAROSMIA (smell hot electric wire (on and off)) and TASTE DISORDER (tasted weird things in mouth) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017B21A) for COVID-19 vaccination.     Concomitant products included HYDROXYZINE for Cystitis interstitial.    On 30-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Mar-2021, the patient experienced CYSTITIS INTERSTITIAL (interstitial cystitis was improved), PAROSMIA (smell hot electric wire (on and off)) and TASTE DISORDER (tasted weird things in mouth). The patient was treated with MELATONIN at a dose of 1 mg once. On 31-Mar-2021, PAROSMIA (smell hot electric wire (on and off)) and TASTE DISORDER (tasted weird things in mouth) had resolved. At the time of the report, CYSTITIS INTERSTITIAL (interstitial cystitis was improved) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Action taken with mRNA-1273 in response to the event was Not Applicable.     This case was linked to US-MODERNATX, INC.-MOD-2021-092725 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-092725:1st dose case
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Eating disorder, Fall, Heart rate, Hypokinesia
Clinical narrative: Fell off the Bed; Not Talking, not responding; Does Not Eat Anything; This spontaneous case was reported by a consumer and describes the occurrence of FALL (Fell off the Bed), HYPOKINESIA (Not Talking, not responding) and EATING DISORDER (Does Not Eat Anything) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Apr-2021, the patient experienced FALL (Fell off the Bed), HYPOKINESIA (Not Talking, not responding) and EATING DISORDER (Does Not Eat Anything). At the time of the report, FALL (Fell off the Bed), HYPOKINESIA (Not Talking, not responding) and EATING DISORDER (Does Not Eat Anything) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: normal (normal) normal. On an unknown date, Heart rate: normal (normal) normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications information was reported. No treatment medications were provided. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Product dose omission issue, Pruritus, Urticaria
Clinical narrative: Patient has passed 35 days without second dose; Developed hives all over the body; Body itching; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 29-Apr-2021 and was forwarded to Moderna on 29-Apr-2021.    This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (Developed hives all over the body), PRURITUS (Body itching) and PRODUCT DOSE OMISSION ISSUE (Patient has passed 35 days without second dose) in an 84-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032A20A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, the patient experienced URTICARIA (Developed hives all over the body) and PRURITUS (Body itching). On 29-Apr-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (Patient has passed 35 days without second dose). At the time of the report, URTICARIA (Developed hives all over the body), PRURITUS (Body itching) and PRODUCT DOSE OMISSION ISSUE (Patient has passed 35 days without second dose) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information included Steroid shot, Prednisolone, Sodium Chloride, Diphenhydramine, Methyl prednisone and Famotidine.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Arthritis, Asthenia, Chills, Fatigue
Clinical narrative: Cramping and stomach pain; Still not herself and energy level is low; Just doesn't feel good, still not herself; IBS that flared up; Arthritis flared up in her knee; Fatigued; Headache; Fever; Nausea; muscle pain; Chills; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN UPPER (Cramping and stomach pain), ASTHENIA (Still not herself and energy level is low), FEELING ABNORMAL (Just doesn't feel good, still not herself), IRRITABLE BOWEL SYNDROME (IBS that flared up) and ARTHRITIS (Arthritis flared up in her knee) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 048B21A and 007B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Panic attack on 25-Sep-1989. Concurrent medical conditions included Thyroid disorder NOS since 25-Sep-2010, Irritable bowel syndrome and Arthritis.   On 23-Mar-2021 at 5:15 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Apr-2021 at 5:15 PM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 21-Apr-2021, the patient experienced CHILLS (Chills). On 21-Apr-2021 at 2:00 AM, the patient experienced MYALGIA (muscle pain). On 21-Apr-2021 at 8:00 PM, the patient experienced ABDOMINAL PAIN UPPER (Cramping and stomach pain), ASTHENIA (Still not herself and energy level is low), FEELING ABNORMAL (Just doesn't feel good, still not herself), IRRITABLE BOWEL SYNDROME (IBS that flared up), ARTHRITIS (Arthritis flared up in her knee), FATIGUE (Fatigued), HEADACHE (Headache), PYREXIA (Fever) and NAUSEA (Nausea). At the time of the report, ABDOMINAL PAIN UPPER (Cramping and stomach pain), ASTHENIA (Still not herself and energy level is low), FEELING ABNORMAL (Just doesn't feel good, still not herself), IRRITABLE BOWEL SYNDROME (IBS that flared up), ARTHRITIS (Arthritis flared up in her knee), FATIGUE (Fatigued), HEADACHE (Headache), MYALGIA (muscle pain), PYREXIA (Fever) and NAUSEA (Nausea) had not resolved and CHILLS (Chills) outcome was unknown. Not Provided          No Treatment medications were provided.  No  Concomitant medications were provided.   This case was linked to MOD-2021-098146 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 04-Jun-2021: patient demographic details, historical diseases, start date of event  and new events were updated. On 16-Jul-2021: follow-up received on 16-JUL-2021 and contains Non-significant information. On 12-Aug-2021: Follow up included no new Information
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Headache, Irritable bowel syndrome, Myalgia, Nausea
Clinical narrative: Cramping and stomach pain; Still not herself and energy level is low; Just doesn't feel good, still not herself; IBS that flared up; Arthritis flared up in her knee; Fatigued; Headache; Fever; Nausea; muscle pain; Chills; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN UPPER (Cramping and stomach pain), ASTHENIA (Still not herself and energy level is low), FEELING ABNORMAL (Just doesn't feel good, still not herself), IRRITABLE BOWEL SYNDROME (IBS that flared up) and ARTHRITIS (Arthritis flared up in her knee) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 048B21A and 007B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Panic attack on 25-Sep-1989. Concurrent medical conditions included Thyroid disorder NOS since 25-Sep-2010, Irritable bowel syndrome and Arthritis.   On 23-Mar-2021 at 5:15 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Apr-2021 at 5:15 PM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 21-Apr-2021, the patient experienced CHILLS (Chills). On 21-Apr-2021 at 2:00 AM, the patient experienced MYALGIA (muscle pain). On 21-Apr-2021 at 8:00 PM, the patient experienced ABDOMINAL PAIN UPPER (Cramping and stomach pain), ASTHENIA (Still not herself and energy level is low), FEELING ABNORMAL (Just doesn't feel good, still not herself), IRRITABLE BOWEL SYNDROME (IBS that flared up), ARTHRITIS (Arthritis flared up in her knee), FATIGUE (Fatigued), HEADACHE (Headache), PYREXIA (Fever) and NAUSEA (Nausea). At the time of the report, ABDOMINAL PAIN UPPER (Cramping and stomach pain), ASTHENIA (Still not herself and energy level is low), FEELING ABNORMAL (Just doesn't feel good, still not herself), IRRITABLE BOWEL SYNDROME (IBS that flared up), ARTHRITIS (Arthritis flared up in her knee), FATIGUE (Fatigued), HEADACHE (Headache), MYALGIA (muscle pain), PYREXIA (Fever) and NAUSEA (Nausea) had not resolved and CHILLS (Chills) outcome was unknown. Not Provided          No Treatment medications were provided.  No  Concomitant medications were provided.   This case was linked to MOD-2021-098146 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 04-Jun-2021: patient demographic details, historical diseases, start date of event  and new events were updated. On 16-Jul-2021: follow-up received on 16-JUL-2021 and contains Non-significant information. On 12-Aug-2021: Follow up included no new Information
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Cramping and stomach pain; Still not herself and energy level is low; Just doesn't feel good, still not herself; IBS that flared up; Arthritis flared up in her knee; Fatigued; Headache; Fever; Nausea; muscle pain; Chills; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN UPPER (Cramping and stomach pain), ASTHENIA (Still not herself and energy level is low), FEELING ABNORMAL (Just doesn't feel good, still not herself), IRRITABLE BOWEL SYNDROME (IBS that flared up) and ARTHRITIS (Arthritis flared up in her knee) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 048B21A and 007B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Panic attack on 25-Sep-1989. Concurrent medical conditions included Thyroid disorder NOS since 25-Sep-2010, Irritable bowel syndrome and Arthritis.   On 23-Mar-2021 at 5:15 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Apr-2021 at 5:15 PM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 21-Apr-2021, the patient experienced CHILLS (Chills). On 21-Apr-2021 at 2:00 AM, the patient experienced MYALGIA (muscle pain). On 21-Apr-2021 at 8:00 PM, the patient experienced ABDOMINAL PAIN UPPER (Cramping and stomach pain), ASTHENIA (Still not herself and energy level is low), FEELING ABNORMAL (Just doesn't feel good, still not herself), IRRITABLE BOWEL SYNDROME (IBS that flared up), ARTHRITIS (Arthritis flared up in her knee), FATIGUE (Fatigued), HEADACHE (Headache), PYREXIA (Fever) and NAUSEA (Nausea). At the time of the report, ABDOMINAL PAIN UPPER (Cramping and stomach pain), ASTHENIA (Still not herself and energy level is low), FEELING ABNORMAL (Just doesn't feel good, still not herself), IRRITABLE BOWEL SYNDROME (IBS that flared up), ARTHRITIS (Arthritis flared up in her knee), FATIGUE (Fatigued), HEADACHE (Headache), MYALGIA (muscle pain), PYREXIA (Fever) and NAUSEA (Nausea) had not resolved and CHILLS (Chills) outcome was unknown. Not Provided          No Treatment medications were provided.  No  Concomitant medications were provided.   This case was linked to MOD-2021-098146 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 04-Jun-2021: patient demographic details, historical diseases, start date of event  and new events were updated. On 16-Jul-2021: follow-up received on 16-JUL-2021 and contains Non-significant information. On 12-Aug-2021: Follow up included no new Information
Sex: F
Vaccine: COVID19
Symptoms: Chills, Influenza like illness, Pain, Rash, Vaccination site erythema
Clinical narrative: Achy; flu like symptoms; bumpy rash across chest and shoulders; injection site is red; injection site is swollen; Chills; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Achy), INFLUENZA LIKE ILLNESS (flu like symptoms), RASH (bumpy rash across chest and shoulders), VACCINATION SITE ERYTHEMA (injection site is red) and VACCINATION SITE SWELLING (injection site is swollen) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 27-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Apr-2021, the patient experienced PAIN (Achy), INFLUENZA LIKE ILLNESS (flu like symptoms), RASH (bumpy rash across chest and shoulders), VACCINATION SITE ERYTHEMA (injection site is red), VACCINATION SITE SWELLING (injection site is swollen) and CHILLS (Chills). At the time of the report, PAIN (Achy), INFLUENZA LIKE ILLNESS (flu like symptoms), RASH (bumpy rash across chest and shoulders), VACCINATION SITE ERYTHEMA (injection site is red), VACCINATION SITE SWELLING (injection site is swollen) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.   No corrective treatment was provided.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site swelling
Clinical narrative: Achy; flu like symptoms; bumpy rash across chest and shoulders; injection site is red; injection site is swollen; Chills; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Achy), INFLUENZA LIKE ILLNESS (flu like symptoms), RASH (bumpy rash across chest and shoulders), VACCINATION SITE ERYTHEMA (injection site is red) and VACCINATION SITE SWELLING (injection site is swollen) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 27-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Apr-2021, the patient experienced PAIN (Achy), INFLUENZA LIKE ILLNESS (flu like symptoms), RASH (bumpy rash across chest and shoulders), VACCINATION SITE ERYTHEMA (injection site is red), VACCINATION SITE SWELLING (injection site is swollen) and CHILLS (Chills). At the time of the report, PAIN (Achy), INFLUENZA LIKE ILLNESS (flu like symptoms), RASH (bumpy rash across chest and shoulders), VACCINATION SITE ERYTHEMA (injection site is red), VACCINATION SITE SWELLING (injection site is swollen) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.   No corrective treatment was provided.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Arm soreness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm soreness) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included EMPAGLIFLOZIN (JARDIANCE), METFORMIN, INSULIN GLARGINE (LANTUS), LIRAGLUTIDE (VICTOZA) and PIOGLITAZONE for an unknown indication.    On 29-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Mar-2021, the patient experienced PAIN IN EXTREMITY (Arm soreness). The patient was treated with ACETAMINOPHEN at an unspecified dose and frequency and DEXTROMETHORPHAN HYDROBROMIDE (ROBITUSSIN ANTITUS) at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Arm soreness) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Adverse reaction, Nausea
Clinical narrative: Very little reaction; Queasy stomach; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE REACTION (Very little reaction) and NAUSEA (Queasy stomach) in an 81-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 062G204) for COVID-19 vaccination.     The patient's past medical history included COVID-19 virus test positive in December 2020.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ADVERSE REACTION (Very little reaction) and NAUSEA (Queasy stomach). At the time of the report, ADVERSE REACTION (Very little reaction) and NAUSEA (Queasy stomach) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not provided. Treatment information was not provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-098344, US-MODERNATX, INC.-MOD-2021-029709, US-MODERNATX, INC.-MOD-2021-029709 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 25-May-2021: TCR attached-NNI; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-098344:cross linked - appears to be the case assigned for the 2nd vaccine US-MODERNATX, INC.-MOD-2021-029709:Cross linked US-MODERNATX, INC.-MOD-2021-029709:cross linked
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: Dizzy spells/ aggravating; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizzy spells/ aggravating) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018B21A) for COVID-19 vaccination.     No medical history is provided by the reporter.  Concomitant products included BUDESONIDE, FORMOTEROL FUMARATE (SYMBICORT) for an unknown indication.    On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (Dizzy spells/ aggravating). At the time of the report, DIZZINESS (Dizzy spells/ aggravating) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment information was provided.  Patient stated  he was not going to get the second dose until he gets the event under control.   Most recent FOLLOW-UP information incorporated above includes: On 29-Apr-2021: Follow-up received on 20-APR-2021 contains no new information.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Arthritis
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of arthritis (after the second dose it became much worse; with pain to her right hip and knee) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 027A21A and 036B21A) for COVID-19 immunization. No medical history reported. On Mar 17, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Apr 24, 2021, patient received the second dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Mar 17, 2021, patient had arthritis (after the second dose it became much worse; with pain to her right hip and knee). The patient treated with tramadol, at an unspecified dose; and frequency and ibuprofen, at an unspecified dose and frequency. At the time of the report, arthritis (after the second dose it became much worse; with pain to her right hip and knee) outcome: unknown/not provided. No concomitant medication provided. This case linked to MOD-2021-098139 (patient link). Most recent follow-up information incorporated: On Jun 28, 2021: Follow-up information received on Apr 29, 2021 included outcome of the event. Updated from unknown to recovered.